Premarket Losers

AMPG FILES FOR SHELF REGISTRATION TO REPLACE EXPIRED IDENTICAL SHELF WITHOUT DILUTION, REINFORCING FINANCIAL STABILITY

News

hauppauge, ny, april 16, 2024 – amplitech group, inc (nasdaq: ampg), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5g, and other communications networks, including the design of complete 5g/6g systems, and a global distributor of packages and lids for integrated circuit assembly, today announced it has filed with sec a shelf registration

BERKSHIRE HILLS BANCORP ANNOUNCES RESULTS OF ANNUAL MEETING

News

shareholders recognize berkshire's achievements; approve all proposals boston , may 17, 2024  /prnewswire/ -- berkshire hills bancorp, inc. (nyse: bhlb), the parent company of berkshire bank, a relationship-driven, community-focused bank with financial centers in new england and new york, announced today that all three proposals were approved at its annual meeting of shareholders on may 16, 2024, with a quorum of approximately 91% of outstanding shares voted in person or by proxy at the meeting.  all measures were unanimously recommended by the board.

HEARTSCIENCES ANNOUNCES GRANT OF FUNDAMENTAL PATENT BY THE EUROPEAN PATENT OFFICE COVERING ASSESSMENT OF DIASTOLIC FUNCTION OF THE HEART USING AI-ECG

News

patent covers use of ai-ecg for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease patent covers use of ai-ecg for any echo measure of diastolic function, which is crucial for heart screening and early detection of heart disease

GAMESTOP ANNOUNCES FIRST QUARTER PRELIMINARY RESULTS

News

grapevine, texas, may 17, 2024 (globe newswire) -- gamestop corp. (nyse: gme) (“gamestop” or the “company”) today announced certain preliminary unaudited financial information for the first quarter ended may 4, 2024.

DXC TECHNOLOGY AND FERROVIAL TO CO-CREATE NEW GENERATIVE ARTIFICIAL INTELLIGENCE PLATFORM

News

quercus will help organizations adopt generative ai to accelerate innovation and optimize business processes ashburn, va. , may 17, 2024 /prnewswire/ -  dxc technology  (nyse: dxc), a leading fortune 500 global technology services provider, will work with ferrovial (nasdaq: fer), one of the world's leading infrastructure companies, and microsoft to jointly develop the generative artificial intelligence (ai) platform quercus.

E-HOME HOUSEHOLD SERVICES HOLDINGS LIMITED'S CHUANG YING BUSINESS STUDIES RELIES ON AI TECHNOLOGY TO DEVELOP ITS OWN SERVICE PLATFORM FOR PROFESSIONAL TALENTS FOR ENTERPRISE POSITIONS, ENABLING ENTERPRISES TO CULTIVATE TALENTS MORE EFFICIENTLY

News

fuzhou, china , may 17, 2024 /prnewswire/ -- e-home household services holdings limited (nasdaq:ejh) (the "company" or "e home"), an integrated home services provider in china, the company today announced that ehome's holding company, fujian province chuang ying business learning technology co., ltd. has developed its own enterprise professional skills learning platform system based on ai technology.

LUCY SCIENTIFIC DISCOVERY INC. ANNOUNCES 1-FOR-10 REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID REQUIREMENT

News

vancouver, british columbia--(business wire)--lucy scientific discovery inc. (nasdaq: lsdi), a company dedicated to advancing the understanding and applications of psychotropic medicines, improving mental health outcomes, and enhancing well-being for individuals worldwide announces that the company will effect a one-for-ten (1-10) reverse split of its common shares. the company is effecting the reverse split in an effort to regain compliance with the $1.00 minimum bid price required for continu.

DERMATA THERAPEUTICS ANNOUNCES EXERCISE OF WARRANTS FOR $2.66 MILLION IN GROSS PROCEEDS PRICED AT-THE-MARKET UNDER NASDAQ RULES

News

san diego, ca / accesswire / may 17, 2024 / dermata therapeutics, inc. (nasdaq:drma)(nasdaq:drmaw) ("dermata," or the "company"), a late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases and conditions, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 516,336 shares of the company's common stock, having exercise prices of $9.7665 and $32.40 per share, issued by dermata in november 2023 (with respect to 462,945 warrants) and may 2023 (with respect to 53,391 warrants), at a reduced exercise price of $5.16 per share. the shares of common stock issuable upon exercise of the warrants are registered pursuant to effective registration statements on form s-3 (file no.

BLUE STAR FOODS ANNOUNCES 1-FOR-50 REVERSE STOCK SPLIT

News

miami, fl, may 15, 2024 (globe newswire) -- blue star foods corp., (“blue star,” the “company,” “we,” “our” or “us”) (nasdaq: bsfc ), an integrated environmental, social, and governance (esg) sustainable seafood company with a focus on recirculatory aquaculture systems (ras), today announced that it will effect a 1-for-50 reverse stock split ("reverse stock split") of its authorized and issued and outstanding shares of class a common stock, par value $0.0001 per share ("common stock"). the reverse stock split will become effective at 12:01am, eastern time, on may 20, 2024. at such time, each 50 shares of issued and outstanding common stock will automatically be reclassified into one new share of common stock. the total number of shares of common stock authorized for issuance will remain at 100,000,000 shares. proportional adjustments will be made to outstanding equity awards, warrants and convertible notes, and to the number of shares issued and issuable under the company's stock incentive plans and certain existing agreements. no fractional shares will be issued in connection with the reverse stock split. all fractional shares will be rounded up. the reverse stock split will affect all common stockholders uniformly and will not alter any stockholder's percentage interest in the company's equity.

CRACKER BARREL PROVIDES UPDATE ON STRATEGIC TRANSFORMATION PLAN AND ANNOUNCES CAPITAL ALLOCATION CHANGES TO DRIVE SUSTAINABLE LONG-TERM VALUE CREATION

News

organic growth investments expected to accelerate financial performance in late fiscal 2026 and into fiscal 2027 company provides update on third and fourth quarter fiscal 2024 lebanon, tenn., may 16, 2024 /prnewswire/ -- cracker barrel old country store, inc. ("cracker barrel" or the "company") (nasdaq: cbrl) today provided an update on its strategic transformation plan and announced changes to its capital allocation.

MEDIACO ACQUIRES ESTRELLA MEDIA'S CONTENT AND DIGITAL OPERATIONS

News

new york & los angeles--(business wire)--mediaco holding inc. (nasdaq: mdia) (“mediaco”) today announced that it has acquired all of estrella media's network, content, digital, and commercial operations. among the estrella media brands joining mediaco are the estrellatv network and its influential linear and digital video content business, and estrella media's expansive digital channels, including its four fast channels – estrellatv, estrella news, cine estrellatv, and estrella games – and the.

EDIBLE GARDEN REPORTS SIGNIFICANT 27.6% YEAR-OVER-YEAR REVENUE GROWTH FOR FIRST QUARTER OF 2024

News

195.8% gross profit increase in q1 2024 with gross margin increasing by 171 basis points 95% of edible garden fresh product line being produced at company-owned facilities - strategic pivot away from third-party growers marks a turn toward higher expected profits vertical integration expected to pay off - company plans to boost margins in the coming quarters conference call to be held today at 8:00 am et. belvidere, n.j.

LED LIGHTING AND EV CHARGING SOLUTIONS PROVIDER ORION PREVIEWS FY 2024 RESULTS IN ANTICIPATION OF ITS SINGULAR RESEARCH WEBINAR PRESENTATION WED. MAY 22 AT 3PM ET

News

led lighting and ev charging solutions provider orion previews fy 2024 results ahead of its singular research webinar presentation, wed. 5/22 at 3pm et.

GLOBAVEND HOLDINGS LIMITED ENTERS INTO A US$20,000,000 EQUITY LINE OF CREDIT FACILITY TO BE REGISTERED ON FORM F-1

News

perth, australia, march 18, 2024 (globe newswire) -- globavend holdings limited (nasdaq: gvh) (the “company” or “globavend”), an emerging e-commerce logistics provider, is pleased to announce that it has entered into a us$20,000,000 equity purchase agreement (the “equity purchase agreement”) with square gate capital master fund, llc – series 1 (“square gate”), as well as a registration rights agreement (“registration right agreement”) related thereto. pursuant to the terms of the registration rights agreement, the company will register the company's ordinary shares (the “shares”) issuable to square gate under the equity purchase agreement for public resale.

KOSS CORPORATION RELEASES THIRD QUARTER RESULTS

News

milwaukee, wis., may 09, 2024 (globe newswire) -- koss corporation (nasdaq: koss) (the “company”), a u.s. based high-fidelity headphone company, has reported its results for the third quarter ended march 31, 2024.

BON NATURAL LIFE LIMITED ANNOUNCES BRAND STRATEGIC COOPERATION WITH GUANGDONG JUWO

News

xi'an, china, may 14, 2024 (globe newswire) -- bon natural life limited (nasdaq: bon) (“bon” or the “company”), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced that its operating subsidiary, xi'an app-chem bio (tech) co., ltd., reached a strategic cooperation agreement with guangdong juwo trading co., ltd.

AGBA SOLIDIFIES MARKET LEADERSHIP WITH EXPANSION PLANS AND FOCUS ON TECH/FINTECH INNOVATION

News

los angeles, may 15, 2024 (globe newswire) -- nasdaq-listed, agba group holding limited (“agba” or the “company” or the “group”), the leading one-stop financial supermarket in hong kong released its financial results for the first quarter of 2024.

SILVERSUN TECHNOLOGIES REPORTS FIRST QUARTER 2024 RESULTS

News

east hanover, nj / accesswire / may 7, 2024 / silversun technologies, inc. (nasdaq:ssnt), a national provider of transformational business technology solutions and services, today announced its first quarter results for the three months ended march 31, 2024. financial highlights for three months ended march 31, 2024 as compared to three months ended march 31, 2023: total revenue was $14,435,555, compared with $13,127,738, an increase of 10.0%.

AEGIS CAPITAL CORP. ACTED AS SOLE BOOKRUNNER ON A $7.0 MILLION UNDERWRITTEN PUBLIC OFFERING FOR BYND CANNASOFT ENTERPRISES INC. (NASDAQ: BCAN)

News

new york, ny / accesswire / march 18, 2024 / aegis capital corp. acted as sole bookrunner on a $7.0 million underwritten public offering for bynd cannasoft enterprises inc. (nasdaq:bcan). about bynd cannasoft enterprises inc. bynd cannasoft enterprises inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in israel.

LOTTERY.COM ANNOUNCES APPOINTMENT OF NEW STRATEGIC FINANCIAL ADVISER TO ACCELERATE AND EXPAND GLOBAL REACH AND ACQUISITION STRATEGY

News

new york, may 13, 2024 (globe newswire) -- lottery.com inc. (nasdaq: ltry, ltry), a leading technology company transforming how, where, and when lottery and sports media content is delivered, today announces a significant step to accelerate its global expansion efforts. lottery.com has engaged cohen & company capital markets ("ccm"), a division of j.v.b. financial group, llc, as its financial advisor to help oversee and structure its acquisition strategy. the company's “buy and build” strategy is backed by the united capital investments limited (“ucil”) $150 million loan facility with support from strategic investors, such as prosperity investment management.

AEYE REPORTS FIRST QUARTER 2024 RESULTS

News

dublin, calif.--(business wire)--aeye, inc. (nasdaq: lidr), a global leader in adaptive, high performance lidar solutions, today announced its results for the first quarter ended march 31, 2024. management commentary “aeye made incredible progress with our capital-light partnership model in the first quarter, including significantly expanding our strategic opportunities and opening the door to the booming lidar market in china. the first product from our 4sight flex reference design, apollo, ha.

DYNATRONICS CORPORATION REPORTS THIRD QUARTER FISCAL YEAR 2024 FINANCIAL RESULTS

News

eagan, minnesota--(newsfile corp. - may 9, 2024) - dynatronics corporation (nasdaq: dynt) ("dynatronics" or the "company"), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2024 ended march 31, 2024. ceo commentary "we continue to make progress on achieving our sales goals and finding our path to positive ebitda," said brian baker, chief executive officer of dynatronics.

P3 HEALTH PARTNERS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

News

henderson, nev.--(business wire)--p3 health partners inc. (“p3” or the “company”) (nasdaq: piii), today reported that the board of directors (the “board”) (including the independent members of the board) approved the award of employment inducement equity grants to aric coffman, m.d. in connection with his agreement to serve as the company's chief executive officer and president as follows: effective as of may 9, 2024, the grant of an employment inducement stock option award covering 12,100,000.

NEXIMMUNE ANNOUNCES CLOSING OF $3.67 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES

News

gaithersburg, md., feb. 06, 2024 (globe newswire) -- neximmune, inc. a biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific t cells in oncology, autoimmune and infectious diseases, today announced the closing of its previously announced registered direct offering of 304,731 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $12.05 per share (or per common stock equivalent in lieu thereof) in a registered direct offering priced at-the-market under nasdaq rules.

STRAN & COMPANY POSTPONES 2024 FIRST QUARTER EARNINGS CONFERENCE CALL

News

quincy, ma, may 13, 2024 (globe newswire) -- stran & company, inc. ("stran" or the "company") (nasdaq: swag) (nasdaq: swagw), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, reports that it has postponed its 2024 first quarter investor conference call due to the recent required dismissal of the company's former independent registered public accounting firm. the company is selecting its new auditor and plans to announce a new date and time for the conference call to report its preliminary unaudited financial results for the first quarter of 2024 as soon as practicable.

SENMIAO TECHNOLOGY REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENT

News

chengdu, china , march 28, 2024 /prnewswire/ -- senmiao technology limited ("senmiao" or the "company") (nasdaq: aihs), a financing and servicing company focused on the online ride-hailing industry in china as well as an operator of its own online ride-hailing platform, today announced that it has received a letter from the nasdaq listing qualifications staff, dated march 26, 2024, notifying the company that it has regained compliance with the minimum bid price requirement under the listing rules of the nasdaq stock market. the letter noted that as a result of the closing bid price of the company's common stock having been at $1.00 per share or greater for 20 consecutive business days, from february 27, 2024 to march 25, 2024, the company has regained compliance with listing rule 5550(a)(2), and the matter is now closed.

STRONG GLOBAL ENTERTAINMENT REPORTS FIRST QUARTER 2024 OPERATING RESULTS

News

mooresville, n.c., may 14, 2024 (globe newswire) -- strong global entertainment, inc. (nyse american: sge) (the “company” or “strong global entertainment”) today announced operating results for the first quarter ended march 31, 2024.

BRERA HOLDINGS CONGRATULATES 2024 FENIX TROPHY CHAMPIONS FC UNITED OF MANCHESTER

News

third edition of uefa-recognized social impact soccer tournament covered by espn and other media outlets dublin, ireland and milan, italy--(newsfile corp. - may 17, 2024) - brera holdings plc (nasdaq: brea) ("brera holdings" or the company") congratulates fc united of manchester, the 2024 fenix trophy tournament champions. the fenix trophy, in its third season, is for semi-professional and amateur clubs which are fan-owned or have a strong community ethos.

HANRYU HOLDINGS, INC. ANNOUNCES RECEIPT OF A DELINQUENCY COMPLIANCE ALERT NOTICE FROM NASDAQ

News

seoul, republic of south korea, april 24, 2024 (globe newswire) -- hanryu holdings, inc. (nasdaq: hryu) (“hanryu” or the “company”), a media-tech company and creator of fantoo, an all-in-one social media experience connecting k-culture fans globally, today announced that on april 18, 2024, it received a delinquency compliance alert notice from the listing qualifications department of the nasdaq stock market llc (“nasdaq”) advising the company that due to the company's failure to timely file its annual report on form 10-k for the fiscal year ended december 31, 2023, with the securities and exchange commission (the “sec”), the company is not in compliance with nasdaq's continued listing requirements under nasdaq listing rule 5250(c)(1) (the “rule”), which requires the timely filing of all required periodic reports with the sec.

CREDICORP LTD.: CREDICORP'S EARNINGS RELEASE AND CONFERENCE CALL 1Q24

News

lima, april 26, 2024 (globe newswire) -- lima, peru, april 26th, 2024 – credicorp ltd. announces to its shareholders and the market that its 1q24 earnings release report will be released on thursday, may 9th, 2024, after market close.

AMERICAN ONCOLOGY NETWORK APPOINTS NEW BOARD MEMBER

News

fort myers, fla., may 16, 2024 (globe newswire) -- american oncology network (aon) (nasdaq: aonc), one of the nation's fastest-growing networks of community oncology practices, is pleased to announce the appointment of william “bill” j.

ONTRAK HEALTH ANNOUNCES 2024 FIRST QUARTER FINANCIAL RESULTS

News

miami--(business wire)--ontrak, inc. (nasdaq: otrk) (“ontrak” or the “company”), a leading ai-powered and technology-enabled behavioral healthcare company, today reported its financial results for the first quarter ended march 31, 2024. management commentary “we are thrilled to announce our approval by the florida agency for health care administration (ahca) as a subcontractor for our new customer, community care plan, a south florida-based health plan to serve its adult medicaid population,” s.

GLOBANT REPORTS 2024 FIRST QUARTER FINANCIAL RESULTS

News

executing on growth initiatives first quarter revenues of $571.1 million, up 20.9% year-over-year ifrs diluted eps of $1.02 for the first quarter non-ifrs adjusted diluted eps of $1.53 for the first quarter luxembourg , may 16, 2024 /prnewswire/ -- globant (nyse: glob), a digitally native company focused on reinventing businesses through innovative technology solutions, today announced results for the three months ended march 31, 2024. please see highlights below, including certain non-ifrs measures.

ABSTRACT ON PHASE 2 STUDY WITH IMUNON'S IMNN-001 PLUS BEVACIZUMAB ACCEPTED FOR PRESENTATION AT THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING

News

lawrenceville, n.j., may 15, 2024 (globe newswire) -- imunon, inc.  (nasdaq: imnn), a clinical-stage drug-development company focused on developing non-viral dna-mediated immunotherapy and next-generation vaccines, announces that an abstract describing a phase 2 study with imnn-001 plus bevacizumab (avastin®) and neoadjuvant chemotherapy in advanced epithelial ovarian cancer patients has been accepted for presentation at the american society of clinical oncology (asco) annual meeting, to be held in chicago from may 31st to june 4th.

RETO ANNOUNCES FILING OF ANNUAL REPORT ON FORM 20-F

News

beijing , may 15, 2024 /prnewswire/ -- reto eco-solutions, inc. (nasdaq: reto) ("reto" or the "company"), a provider of technology solutions and operation services for intelligent ecological environments and internet of things technology development services in china and other countries, today announced the filing of its annual report on form 20-f, containing audited consolidated financial statements for the fiscal year ended december 31, 2023, with the securities and exchange commission on may 15, 2024. a copy of the annual report is available on its website (http://en.retoeco.com/tzzcw.html?1/).

WEARABLE DEVICES LTD. SECURES PATENT FOR ITS AI GESTURE-CONTROLLED INTERFACE IN CHINA

News

the new granted patent broadens wearable devices global patents portfolio to the eastern markets yokneam illit, israel, may 16, 2024 (globe newswire) -- wearable devices ltd. (the “company” or “wearable devices”) (nasdaq: wlds, wldsw), a technology growth company specializing in touchless sensing wearables powered by artificial intelligence (“ai”), announced that the china national intellectual property administration granted its patent application, no.

KIDPIK REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

new york--(business wire)--kidpik corp. (“kidpik” or the “company”), an online clothing subscription-based e-commerce company, today reported its financial results for the first quarter 2024 ended march 30, 2024. first quarter 2024 highlights: revenue, net: was $2.2 million, a year over year decrease of 44.4%. gross margin: was 69.9%, compared to 59.8% in the first quarter of 2023. shipped items: were 195,000 items, compared to 340,000 shipped items in the first quarter of 2023. average shipmen.

TDH HOLDINGS, INC. REPORTS FULL YEAR 2023 AUDITED FINANCIAL RESULTS

News

qingdao, china , april 29, 2024 /prnewswire/ -- tdh holdings, inc. (nasdaq: petz) ("tdh" or the "company"), a prc-based company that is an operator of a restaurant in the u.s., announced today its financial results for the fiscal year ended december 31, 2023. full year 2023 financial highlights:  for the twelve months ended december 31,   ($ millions, except per share data)  2023 2022  % change    revenues from continuing operations  $3.18 $3.10 2.49 %  gross profit  1.03 1.05 (0.02)  gross margin  0.32 0.34 -1.55 pp*  loss from operations  (6.37) (3.05) (1.09)  operating loss margin  (2.01) (0.98) -102.19 pp*  net loss attributable to common stockholders  (23.63) 0.80 (30.40)  loss per share - basic and diluted  (2.29) 0.10 (23.87)  * pp: percentage points    revenues from continuing operations increased by 2.49% from $3.10 million in fiscal year 2022 to $3.18 million in fiscal year 2023.

MAIA BIOTECHNOLOGY TO PRESENT AT THE BIO INTERNATIONAL CONVENTION 2024

News

chicago--(business wire)--maia biotechnology to present at the bio international convention 2024.

MAISON SOLUTIONS RELEASES POST-ACQUISITION WEBINAR DETAILING RECENT EXPANSION INTO ARIZONA

News

monterey park, ca / accesswire / april 19, 2024 / maison solutions inc. ("maison solutions" or the "company"), (nasdaq:mss), a u.s.-based specialty grocery retailer offering traditional asian and international food and merchandise, today released a pre-recorded webinar providing additional information on the three recently acquired arizona-based lee lee international supermarket chain markets. the webinar is available for replay via the investor relations section of the company's website.

EXPION360 ANNOUNCES NEW ONLINE RETAIL PARTNERSHIP WITH TRACTOR SUPPLY COMPANY

News

redmond, ore., may 16, 2024 (globe newswire) -- expion360 inc. (nasdaq: xpon) (“expion360” or the “company”), an industry leader in lithium-ion battery power storage solutions, announced a new e-commerce retail partnership with tractor supply company (“tractor supply”), the largest rural lifestyle retailer in the united states, to offer expion360 products online for shipment to customers in 49 states.

COHEN & COMPANY REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

net income attributable to cohen & company inc. of $2.0 million, or $1.28 per diluted share adjusted pre-tax income of $7.7 million, or $1.37 per diluted share board declares quarterly dividend of $0.25 per share philadelphia and new york, may 06, 2024 (globe newswire) -- cohen & company inc. (nyse american: cohn), a financial services firm specializing in an expanding range of capital markets and asset management services, today reported financial results for its first quarter ended march 31, 2024. summary operating results     three months ended ($ in thousands) 3/31/24   12/31/23   3/31/23             net trading $ 9,848     $ 7,809     $ 8,210   asset management   2,717       1,919       2,025   new issue and advisory   24,388       18,722       900   principal transactions and other revenue   (18,389 )     6,014       (2,311 ) total revenues   18,564       34,464       8,824   compensation and benefits   14,839       16,335       10,537   non-compensation operating expenses   7,100       6,680       5,770   goodwill impairment   -       -       -   operating income (loss)   (3,375 )     11,449       (7,483 ) interest expense, net   (1,666 )     (1,619 )     (1,592 ) other non-operating income   -       -       -   income (loss) from equity method affiliates   29,045       17,217       (395 ) income (loss) before income tax expense (benefit)   24,004       27,047       (9,470 ) income tax expense (benefit)   498       166       584   net income (loss)   23,506       26,881       (10,054 ) less: net income (loss) attributable to the non-convertible non-controlling interest   16,270       11,054       97   enterprise net income (loss)   7,236       15,827       (10,151 ) less: net income (loss) attributable to the convertible non-controlling interest   5,213       11,279       (7,514 ) net income (loss) attributable to cohen & company inc. $ 2,023     $ 4,548     $ (2,637 ) fully diluted net income (loss) per share $ 1.28     $ 2.97     $ (1.77 )             adjusted pre-tax income (loss) (1) $ 7,734     $ 15,993     $ (9,567 ) fully diluted adjusted pre-tax income (loss) per share $ 1.37     $ 2.88     $ (1.74 )             (1)   adjusted pre-tax income (loss) is not a measure recognized under u.s. generally accepted accounting principles (“gaap”).

EGLE THERAPEUTICS STRENGTHENS ITS LEADERSHIP TEAM WITH THE APPOINTMENT OF PEJVACK MOTLAGH, MD, MSC, AS CHIEF MEDICAL OFFICER AND ITS BOARD OF DIRECTORS WITH APPOINTMENT OF JOHN CELEBI, MBA, AS INDEPENDENT BOARD MEMBER

News

paris--(business wire)--egle therapeutics, a clinical-stage biotechnology company uniquely positioned to advance the next generation of regulatory t cell-focused therapies for oncology and auto-immunity, announced today the appointment of pejvack motlagh md, msc, as chief medical officer and john celebi, as independent board member. “we are excited to welcome pejvack and john at egle and to benefit from their strong experience. the appointment of dr motlagh is critical for egle, as the company.

DOLPHIN ENTERTAINMENT IS PROUD TO SHARE THE NEW "BLUE ANGELS" FEATURETTE AHEAD OF THE DOCUMENTARY'S RELEASE IN IMAX THEATERS NATIONWIDE BEGINNING TOMORROW, MAY 17, 2024

News

los angeles, ca / accesswire / may 16, 2024 / dolphin entertainment (nasdaq:dlpn) is proud to share the new "blue angels" featurette ahead of the documentary's release in imax theaters nationwide beginning tomorrow, may 17. the featurette was previously shared exclusively on entertainment weekly.

SENSTAR TECHNOLOGIES ANNOUNCES FILING AND AVAILABILITY OF 2023 ANNUAL REPORT ON FORM 20-F

News

ottawa, on , april 19, 2024 /prnewswire/ -- senstar technologies corporation (nasdaq: snt), a leading international provider of comprehensive physical, video and access control security products and solutions, announced today that its annual report on form 20-f for the year ended december 31, 2023 has been filed with the securities and exchange commission ("sec") and is available on the company's website https://senstartechnologies.com in the investors section under sec filings, as well as from the sec's website www.sec.gov. the annual report is available in the sec filings section on the company's website at www.senstartechnologies.com.

ENVERIC BIOSCIENCES REPORTS FIRST QUARTER 2024 FINANCIAL AND CORPORATE RESULTS

News

cambridge, mass.--(business wire)--enveric biosciences (nasdaq: envb) (“enveric” or the “company”), a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, and addiction disorders, today provided a corporate update and reported financial results for the first quarter of 2024 ended march 31, 2024. “we believe the first quarter of 2024 was a highly productive period for enveric as the company continued to.

QT IMAGING ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS

News

novato, calif.--(business wire)--qt imaging holdings, inc. (nasdaq: qti) (“qt imaging” or the “company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024. qt imaging delivers today the qt imaging breast acoustic ct™ scanner, the only true 3d imaging device, fda cleared for use as a transmission and reflection low frequency soundwaves imaging system for a patient's.

ICAHN ENTERPRISES L.P. ANNOUNCES UPSIZING AND PRICING OF SENIOR NOTES

News

sunny isles beach, fla. , may 13, 2024 /prnewswire/ -- icahn enterprises l.p.

ROSEN, A TRUSTED AND LEADING LAW FIRM, ENCOURAGES MALIBU BOATS, INC. INVESTORS TO SECURE COUNSEL BEFORE IMPORTANT DEADLINE IN SECURITIES CLASS ACTION - MBUU

News

new york , may 17, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of malibu boats, inc. (nasdaq: mbuu) between november 4, 2022 and april 11, 2024, both dates inclusive (the "class period"), of the important june 28, 2024 lead plaintiff deadline. so what: if you purchased malibu boats securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NANOVIRICIDES HAS FILED ITS QUARTERLY REPORT

News

nv-387 advancing to phase ii clinical trial for the treatment of rsv infection shelton, ct / accesswire / may 15, 2024 / nanoviricides, inc. (nyse american:nnvc) (the "company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its quarterly report on form 10-q for the fiscal second quarter ending march 31, 2024 with the securities and exchange commission (sec) on tuesday, may 14, 2024. the report can be accessed at the sec website by searching for the company's filings.

SOL-GEL AND BEIMEI PHARMA ANNOUNCE AN ASSET PURCHASE AGREEMENT TO COMMERCIALIZE TWYNEO® IN THE MAINLAND OF CHINA, HONG KONG, MACAU, TAIWAN AND ISRAEL

News

ness ziona, israel, may 16, 2024 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl), a dermatology company, pioneering treatments for patients with severe skin conditions, conducting a phase 3 clinical trial of sgt-610 (patidegib gel, 2%) for gorlin syndrome, and with two approved large-category dermatology products, twyneo® and epsolay®, today announced that it has signed an asset purchase agreement with chinese based shenzhen beimei pharmaceutical co. ltd, for the commercialization of twyneo, for the treatment of acne vulgaris, in the mainland of china, hong kong, macau, taiwan and israel.

SHAREHOLDER ALERT: PURCELL & LEFKOWITZ LLP ANNOUNCES SHAREHOLDER INVESTIGATION OF CLEARPOINT NEURO, INC. (NASDAQ: CLPT)

News

new york , may 2, 2024 /prnewswire/ -- purcell & lefkowitz llp announces that it is investigating clearpoint neuro, inc. (nasdaq: clpt) on behalf of the company's shareholders.  the investigation seeks to determine whether clearpoint neuro's directors breached their fiduciary duties in connection with recent corporate actions.

METAGENOMI PRESENTS DATA AT SCIENTIFIC CONFERENCES AND FIRST QUARTER 2024 FINANCIAL RESULTS

News

late breaking presentation at world federation of hemophilia (wfh) world congress on investigational development program in hemophilia a; development candidate nomination anticipated in mid-year 2024; 12-month non-human primate durability data expected in 2h 2024

ENLIVEX ANNOUNCES AUTHORIZATION FROM THE DANISH REGULATORY AGENCY FOR THE COMPANY'S RANDOMIZED, CONTROLLED PHASE I/II TRIAL EVALUATING ALLOCETRA IN PATIENTS WITH KNEE OSTEOARTHRITIS

News

nes-ziona, israel, april 16, 2024 (globe newswire) -- enlivex therapeutics ltd. (nasdaq: enlv, the “company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that the danish medicines agency (dkma) authorized the expansion into denmark of the company's multi-country, randomized, controlled phase i/ii trial evaluating allocetratm in up to 160 patients with moderate to severe knee osteoarthritis. as previously announced, the company received its first regulatory approval for this trial from the israeli ministry of health (imoh) in january.

KLINIKUM KLAGENFURT AM WÖRTHERSEE IS LIVE WITH SOPHIA GENETICS

News

the sophia ddm™ platform will help broaden the hospital's cancer testing and diagnostic capabilities boston and rolle, switzerland , may 16, 2024 /prnewswire/ -- sophia genetics (nasdaq: soph), a cloud-native software company and a leader in data-driven medicine, today announced that klinikum klagenfurt am wörthersee, the third largest hospital in austria, is live on the sophia ddm™ platform. the hospital will use sophia genetics' technology to enhance its next-generation sequencing (ngs) testing and deepen its analytical capabilities for solid tumor and blood cancer (hematology oncology) samples.

ORIC PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND OPERATIONAL UPDATES

News

initiated three oric-114 phase 1b expansion cohorts in nsclc patients with egfr exon 20 insertion, her2 exon 20 insertion, or egfr atypical mutations; updated phase 1b data expected in the first half of 2025

MDXHEALTH TO PRESENT AT UPCOMING INVESTOR CONFERENCES

News

mdxhealth to present at upcoming investor conferences irvine, ca, and herstal, belgium – may 15, 2024 (globenewswire) – mdxhealth sa (nasdaq: mdxh), a commercial-stage precision diagnostics company, today announced that michael k. mcgarrity, chief executive officer, will participate in the following investor conferences in june 2024.

SUNPOWER RECEIVES NOTIFICATION OF DEFICIENCY FROM NASDAQ RELATED TO DELAYED FILING OF ANNUAL REPORT ON FORM 10-K

News

richmond, calif. , march 21, 2024 /prnewswire/ -- sunpower (nasdaq:spwr) received on march 20, 2024, a notice (the "notice") from the nasdaq stock market llc ("nasdaq") indicating that the company is not in compliance with nasdaq listing rule 5250(c)(1) (the "listing rule"), which requires timely filing of all required periodic financial reports with the sec, as a result of not having timely filed the form 10-k with the sec, as described more fully in the company's notification of late filing on form 12b-25 filed with the sec on february 29, 2024.

LM FUNDING AMERICA, INC. ACHIEVES OVER 105% YEAR-OVER-YEAR REVENUE GROWTH TO $4.7 MILLION AND GENERATED $1.9 MILLION OF NET INCOME FOR THE FIRST QUARTER OF 2024

News

mined 86.4 bitcoins in q1 2024 valued at approximately $4.6 million at an average  market revenue value of approximately $53,000 per bitcoin

STOCKHOLDER INVESTIGATION: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF AVANGRID, INC. - AGR

News

new york , may 17, 2024 /prnewswire/ -- monteverde & associates pc (the "m&a class action firm"), has recovered money for shareholders and is recognized as a top 50 firm in the 2018-2022 iss securities class action services report. we are headquartered at the empire state building in new york city and is investigating avangrid, inc. (nyse: agr), relating to its proposed merger with iberdrola, s.a.

SIYATA MOBILE REPORTS SIGNIFICANT 30% YEAR-OVER-YEAR REVENUE GROWTH FOR THE FIRST QUARTER OF 2024

News

gross margin expands to 36.6%, up from 27.5% in the year ago period vancouver, bc / accesswire / may 16, 2024 / siyata mobile inc. (nasdaq:syta)(nasdaq:sytaw) (" siyata " or the " company "), a global vendor of push-to-talk over cellular (poc) devices announced its financial results for the three months ended march 31, 2024. marc seelenfreund, ceo of siyata, said, "with revenue growth of 30%, a higher gross margin and solid improvement in adjusted ebitda, our first quarter financial results reflect improvement in our business and the traction we are gaining in the market.

MONOGRAM ORTHOPAEDICS COMPLETES CORPORATE NAME CHANGE TO MONOGRAM TECHNOLOGIES

News

new name reflects continued evolution as an ai-driven robotics company with a strong ip position austin, tx / accesswire / may 15, 2024 / monogram orthopaedics inc. (nasdaq:mgrm) ("monogram" or the "company"), an ai-driven robotics company focused on improving human health with an initial focus on orthopedic surgery, today announced its plan to merge its wholly owned subsidiary, monogram technologies inc. ("mt") with and into monogram orthopaedics inc. in connection with this upstream merger, the current mt will cease to exist, and monogram's business will continue as it is currently being conducted. further, on may 15, 2024, the effective date of the merger, the company will change its name to monogram technologies inc., and its ticker will remain "mgrm.

MAXEON SOLAR TECHNOLOGIES, LTD. BEING INVESTIGATED ON BEHALF OF MAXEON SOLAR TECHNOLOGIES, LTD.

News

new york, ny / accesswire / may 16, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of maxeon solar technologies, ltd. ("maxeon solar technologies, ltd.

EPITOPE BINNING POWERED BY LENSAI TM TECHNOLOGY CAN ANALYZE OVER 5,000 SEQUENCES WITH NO PHYSICAL MATERIALS NEEDED, MATCHES CLASSICAL WET LAB BINNING RESULTS

News

victoria, bc / accesswire / april 22, 2024 / immunoprecise antibodies ltd. (nasdaq:ipa), an ai-driven biotherapeutic research and technology company, has recently announced an expansion of its already successful lensai tm platform.

FIREFLY NEUROSCIENCE, AN AI-DRIVEN BRAIN HEALTH COMPANY, APPOINTS HEALTHCARE-INDUSTRY EXECUTIVE, DAVID JOHNSON AS EXECUTIVE CHAIRMAN, UPON CLOSING OF ITS MERGER TRANSACTION WITH WAVEDANCER

News

fairfax, va. and toronto, may 14, 2024 (globe newswire) -- firefly neuroscience, inc. (“firefly”), a pioneering artificial intelligence (“ai”) company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of david johnson as its executive chairman upon closing of its planned merger with wavedancer, inc. (“wavedancer”) (nasdaq: wavd). firefly has entered into a definitive agreement and plan of merger (as amended, the “merger agreement”) with wavedancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing conditions.

JAGUAR HEALTH, INC. ANNOUNCES REVERSE STOCK SPLIT

News

reverse split approved at april 2024 special meeting of stockholders shares of jaguar health common stock to begin trading on split-adjusted basis on may 23, 2024 san francisco, ca / accesswire / may 17, 2024 / jaguar health, inc. (nasdaq:jagx) ("jaguar" or the "company") today announced that the company will effect a reverse stock split of its issued and outstanding voting common stock ("common stock"), at an exchange ratio of 1-for-60, on thursday, may 23, 2024 (the "effective date") in order to support the company's compliance with nasdaq's listing standards. the company's common stock will begin trading on a split-adjusted basis when the market opens on the effective date and will remain listed on the nasdaq capital market under the symbol "jagx".

ACUMEN PHARMACEUTICALS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

News

charlottesville, va., may 14, 2024 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos) (“acumen” or the “company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (aβos) for the treatment of alzheimer's disease (ad), today reported financial results for the first quarter of 2024 and provided a business update.

SHAREHOLDER INVESTIGATION: THE M&A CLASS ACTION FIRM ANNOUNCES AN INVESTIGATION OF AGRIFY CORPORATION - AGFY

News

new york , may 16, 2024 /prnewswire/ -- monteverde & associates pc (the "m&a class action firm"), has recovered money for shareholders and is recognized as a top 50 firm in the 2018-2022 iss securities class action services report. we are headquartered at the empire state building in new york city and is investigating agrify corporation (nasdaq: agfy), relating to its proposed merger with nature's miracle holding inc. under the terms of the agreement, agrify shareholders will each be issued 0.45 of a share of nature's miracle common stock for each share of agrify common stock that they hold, resulting in agrify shareholders collectively owning approximately 30% of the combined company.

ARTIVION REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

first quarter highlights: achieved revenue of $97.4 million in the first quarter of 2024 versus $83.2 million in the first quarter of 2023, an increase of 17% on a gaap basis and 16% on a non-gaap constant currency basis net income was $7.5 million or $0.18 per fully diluted share and non-gaap net income was $2.6 million or $0.06 per fully diluted share in the first quarter of 2024 non-gaap adjusted ebitda increased 60% to $17.3 million in the first quarter of 2024 compared to $10.8 million in the first quarter of 2023 revised fy24 revenue guidance to 9% to 12% year-over-year growth on a constant currency basis, an increase of 0.5% at the midpoint atlanta , may 6, 2024 /prnewswire/ -- artivion, inc. (nyse: aort), a leading cardiac and vascular surgery company focused on aortic disease, today announced financial results for the first quarter ended march 31, 2024. "we are very pleased with our first quarter results as we maintained growth momentum and executed on key operational priorities.

SONNET BIOTHERAPEUTICS PROVIDES FISCAL YEAR 2024 SECOND QUARTER AND YEAR-TO-DATE BUSINESS AND EARNINGS UPDATE

News

published phase 1 data of son-1010 in frontiers in immunology demonstrating the safety and tolerability of the f h ab-derived interleukin 12 in healthy volunteers announced early safety data from the company's phase 1b/2a clinical trial of son-080 in patients with chemotherapy-induced peripheral neuropathy (cipn) received $4.3 million in net proceeds from the sale of net operating losses through the new jersey technology business tax certificate transfer program presented preclinical data and information on the clinical trial design from the study of son-080 in cipn in a poster session at the american association for cancer research (aacr) annual meeting princeton, nj / accesswire / may 14, 2024 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today its financial results for the three months and six months ended march 31, 2024 and provided a business update. "we are very excited about the progress we made during the first calendar quarter of this year with the son-1010 and son-080 programs, where the foundations for the compounds' safety profiles were further strengthened.

X3 HOLDINGS ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION LETTER REGARDING MINIMUM BID PRICE DEFICIENCY

News

singapore , april 11, 2024 /prnewswire/ -- x3 holdings co., ltd.  (nasdaq: xtkg) (the "company" or "xtkg"), a global provider of digital solutions and technology services spanning diverse industries, today announced that it has received a notification letter (the "notification letter") from the nasdaq stock market llc (the "nasdaq") dated april 10, 2024, notifying the company that it is not in compliance with the minimum bid price requirement as set forth under nasdaq listing rule 5550(a)(2) for continued listing on the nasdaq.

PROTALIX BIOTHERAPEUTICS REPORTS FIRST QUARTER 2024 FINANCIAL AND BUSINESS RESULTS

News

company to host conference call and webcast today at 8:30 a.m. edt carmiel, israel , may 10, 2024 /prnewswire/ -- protalix biotherapeutics, inc. (nyse american: plx), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary procellex® plant cell-based protein expression system, today reported financial results for the quarter ended march 31, 2024, and provided a business and clinical update.

HEARTCORE REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

new york and tokyo, may 14, 2024 (globe newswire) -- heartcore enterprises, inc. (nasdaq: htcr) (“heartcore” or “the company”), a leading enterprise software and consulting services company based in tokyo, reported financial results for the first quarter ended march 31, 2024.

THE REAL GOOD FOOD COMPANY TO PARTICIPATE IN THE 24TH ANNUAL B. RILEY INSTITUTIONAL INVESTOR CONFERENCE

News

cherry hill, n.j., may 15, 2024 (globe newswire) -- the real good food company, inc. (nasdaq: rgf) (“real good foods” or the “company”), a leading health and wellness frozen and refrigerated foods company, today announced that management will participate in the 24th annual b. riley institutional investor conference taking place may 22-23, 2024 in beverly hills, california.

KIRBY MCINERNEY LLP ANNOUNCES INVESTIGATION OF SHAREHOLDER CLAIMS AGAINST INOTIV, INC. (NOTV)

News

new york--(business wire)-- #investigation--the law firm of kirby mcinerney llp is investigating potential claims against inotiv, inc. (“inotiv” or the “company”) (nasdaq: notv). the investigation concerns whether inotiv and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices. [click here to learn more about the investigation] on may 13, 2024, inotiv disclosed that it is unable to timely file its quarterly report on form 10-q for the quarter e.

INNOVATIVE FINGERPRINT DRUG SCREENING SOLUTION SHOWCASED AT THE UK'S PREMIER HEALTH AND SAFETY EVENT

News

new york, may 17, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) ("inbs" or the "company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful exhibition of its intelligent fingerprinting drug screening solution at the health & safety event 2024, the united kingdom's largest annual technology showcase exhibiting products and services that strengthen and support workplace safety standards. according to the event website, this year's event welcomed over 250+ industry-leading exhibitors and over 11,500 attendees, including visitors from major brands such as amazon, pepsico, rolls royce, jaguar land rover, and harvey nichols.

WISDOMTREE SENDS LETTER TO STOCKHOLDERS OUTLINING BOARD OF DIRECTORS' ESSENTIAL BALANCE OF SKILLSETS, EXPERTISE AND INSTITUTIONAL KNOWLEDGE

News

new york--(business wire)--the board of directors of wisdomtree, inc. (nyse: wt), a global financial innovator, today issued a letter urging its stockholders to vote “for” all nine highly qualified members of wisdomtree's board of directors on the white proxy card at the upcoming 2024 annual meeting of stockholders on june 12, 2024. etfs capital limited is targeting three of wisdomtree's directors who provide critical strategic vision, skillsets and institutional knowledge that our board requir.

THE CHEESECAKE FACTORY CELEBRATES MOMS WITH SWEET ONLINE GIFT CARD OFFER

News

calabasas hills, calif.--(business wire)--the cheesecake factory® (nasdaq: cake), known for its extensive menu, generous portions and legendary desserts, is making mother's day shopping sweeter with a special online gift card offer: for every $50 in gift cards purchased online in a single transaction from monday, april 29, 2024 through mother's day, sunday, may 12, 2024, guests will receive a complimentary $10 bonus card redeemable may 13, 2024 through june 5, 2024*. with an extensive menu of m.

SPIRE GLOBAL ANNOUNCES FIRST QUARTER 2024 RESULTS

News

vienna, va.--(business wire)---- $spir--spire global, inc. (nyse: spir) (“spire” or “the company”), a leading provider of space-based data, analytics and space services, today announced results for its quarter ended march 31, 2024. the company will hold a webcast at 5:00 pm et today to discuss the results. “for over a decade, spire's trajectory has been shaped by two enduring global megatrends: global security and the escalating impacts of climate change,” said peter platzer, spire ceo. “since our foundi.

AUGMEDIX DELIVERS 40% REVENUE GROWTH FOR FIRST QUARTER OF 2024

News

san francisco, may 13, 2024 (globe newswire) -- augmedix (nasdaq: augx), a leader in ambient ai medical documentation and data solutions, today reported financial results for the three months ended march 31, 2024.

GREENX TARGETS 10 TO 15 SECURITY TOKEN LAUNCHES IN 2024

News

kuala lumpur, malaysia / accesswire / may 7, 2024 / greenpro capital corp. (nasdaq:grnq) greenx, the leading shariah-compliant esg digital asset exchange licensed by labuan fsa, will be going for at least 10 tokenized offerings by end of year 2024, chief exchange officer philip tam told ifn investor, a leading digital islamic finance publication. full publication of the news can be found at https://articles.ifninvestor.com/green-x-eyeing-10-15-token-launches-in-2024/ philip tam highlights the next security token offering ("sto"), with initial tokenized listing around us$20 mil, would be the largest gemstones collection in southeast asia, "these real-world assets ("rwa") - whether sapphire, rubies, emeralds or diamonds - each have a gemological research association report to certify their intrinsic values.

BIOCARDIA REPORTS FIRST QUARTER 2024 BUSINESS HIGHLIGHTS AND FINANCIAL RESULTS

News

sunnyvale, calif., may 14, 2024 (globe newswire) -- biocardia, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the first quarter of 2024 and filed its quarterly report on form 10-q for the three months ended march 31, 2024 with the securities and exchange commission. the company will also hold a conference call at 4:30 pm et today in which it will discuss business highlights. following management's formal remarks, there will be a question-and-answer session.

DUOS TECHNOLOGIES GROUP REPORTS FIRST QUARTER 2024 RESULTS

News

jacksonville, fla., may 13, 2024 (globe newswire) -- duos technologies group, inc. (“duos” or the “company”) (nasdaq: duot), a provider of machine vision and artificial intelligence that analyzes fast moving vehicles, reported financial results for the first quarter (“q1 2024”) ended march 31, 2024.

ACASTI ANNOUNCES THIRD FISCAL QUARTER 2024 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

News

princeton, n.j., feb. 12, 2024 (globe newswire) -- acasti pharma inc. (nasdaq: acst) (acasti or the company), a late-stage, biopharma company advancing gtx-104, its novel formulation of nimodipine that addresses high unmet medical needs for a rare disease, aneurysmal subarachnoid hemorrhage (asah), today announced financial results and business highlights for the quarter ended december 31, 2023.

VAXART PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS

News

positive results from phase 1 norovirus study in lactating mothers indicate the potential of vaxart's oral pill vaccine candidate to protect or reduce the effect of the disease in infants

EXELIXIS TO WEBCAST FIRESIDE CHATS AS PART OF INVESTOR CONFERENCES IN MAY

News

alameda, calif.--(business wire)--exelixis, inc. (nasdaq: exel) today announced that members of the company's management team will participate in fireside chats at the following investor conferences in may: bofa securities 2024 health care conference: exelixis is scheduled to present at 2:20 p.m. et / 11:20 a.m. pt on tuesday, may 14 in las vegas. citizens jmp life sciences conference: exelixis is scheduled to present at 9:30 a.m. et / 6:30 a.m. pt on tuesday, may 14 in new york city. rbc capit.

TXO PARTNERS DECLARES A FOURTH QUARTER 2023 DISTRIBUTION OF $0.58 ON COMMON UNITS; FILES ANNUAL REPORT ON FORM 10-K

News

fort worth, texas--(business wire)--txo partners, l.p. (nyse: txo) announced today that the board of directors of its general partner declared a distribution of $0.58 per common unit for the quarter ended december 31, 2023. the quarterly distribution will be paid on march 28, 2024, to eligible unitholders of record as of the close of trading on march 15, 2024. “we celebrate the success of our first year as a public company with a secure asset base and a confident business plan for our owners,”.

BTCS REPORTS Q1 2024 RESULTS

News

silver spring, md, may 15, 2024 (globe newswire) -- btcs inc. (nasdaq: btcs) (“btcs” or the “company”), a blockchain technology-focused company, announced its results for the three months ended march 31, 2024 (“q1 2024”).

TRIUMPH TO WEBCAST FOURTH QUARTER FISCAL YEAR 2024 EARNINGS CONFERENCE CALL

News

live webcast scheduled for 8:30 am et on may 23, 2024 radnor, pa. , may 13, 2024 /prnewswire/ -- triumph group, inc. (nyse: tgi) will release fourth quarter fiscal year 2024 earnings on may 23, 2024, and will host a conference call that day at 8:30 a.m.

ATHIRA PHARMA ANNOUNCES PROPOSED SETTLEMENT OF STOCKHOLDER DERIVATIVE ACTION

News

bothell, wash., may 17, 2024 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that the u.s. district court for the western district of washington issued an order providing for preliminary approval of a proposed settlement of the claims asserted nominally on behalf of athira against the individual defendants named in the previously disclosed stockholder derivative actions entitled bushansky v. kawas et al., no. 2:22-cv-497 and houlihan v. kawas et al., no. 2:22-cv-620, pending before the court. the proposed settlement calls for athira to adopt certain corporate governance reforms and pay lead plaintiffs' attorney's fees, litigation expenses, and lead plaintiff service awards.

OUTLOOK THERAPEUTICS® REPORTS FINANCIAL RESULTS FOR SECOND QUARTER FISCAL YEAR 2024 AND PROVIDES CORPORATE UPDATE

News

iselin, n.j., may 15, 2024 (globe newswire) -- outlook therapeutics, inc. (nasdaq: otlk), a biopharmaceutical company working to achieve regulatory approval for the first authorized use of an ophthalmic formulation of bevacizumab for the treatment of retinal diseases, today announced financial results for the second quarter of fiscal year 2024 and provided a corporate update. as previously announced, the company will host its inaugural quarterly conference call and live audio webcast, on thursday, may 16, 2024, at 8:30 am et (details below).

TURNSTONE BIOLOGICS CORP. REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES RECENT BUSINESS HIGHLIGHTS

News

san diego, may 13, 2024 (globe newswire) -- turnstone biologics corp. (“turnstone” or the “company”) (nasdaq: tsbx), a clinical-stage biotechnology company developing a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (selected til) therapy, today reported financial results for the first quarter ended march 31, 2024, and provided recent business highlights. “we are excited about the therapeutic potential of our pipeline of next-generation selected til therapies,” said sammy farah, m.b.a.

ADDENTAX GROUP CORP. ANNOUNCES PRIVATE PLACEMENTS OF ITS COMMON STOCK

News

shenzhen, china , april 29, 2024 /prnewswire/ -- addentax group corp. ("addentax" or the "company") (nasdaq: atxg), an integrated service provider focusing on garment manufacturing, logistics services, property management, and subleasing, has announced that it has entered into private placement agreements (the "agreements") with two investors (the "investors"), who are independent third parties. under the agreements, the company will sell to each of the investor 330,000 shares of common stock at a purchase price of $0.98 per share, resulting in aggregate gross proceeds of $646,800.

FINGERMOTION ENTERING INTO ARRANGEMENTS TO FACILITATE WIDESPREAD USE OF CHARGING TERMINALS FOR SUBSCRIBERS OF THE DA GE APP

News

fingermotion entering into arrangements to facilitate widespread use of charging terminals for subscribers of the da ge app singapore, singapore / accesswire / april 17, 2024 / fingermotion, inc. (nasdaq:fngr) (the "company" or "fingermotion"), a mobile services and data company, today announces that through its contractually controlled entity, shanghai jiuge information technology co., ltd. ("jiuge technology") it is entering into arrangements with certain electric vehicle ("ev") charging station providers in the prc to allow ev owners who have subscribed to the da ge app to locate and charge their vehicles, which is expected to significantly expand da ge's usage.

LOGICMARK, INC. TO PRESENT AT AEGIS CAPITAL CORP. VIRTUAL CONFERENCE ON MAY 9, 2024

News

louisville, ky., may 08, 2024 (globe newswire) -- logicmark, inc.  (nasdaq: lgmk), a provider of personal emergency response systems (pers), health communications devices, and technology for the growing care economy, today announced that ms. chia-lin simmons, ceo, and mr. mark archer, cfo will speak at the virtual aegis capital corp. conference on thursday, may 9th at 11:00 pdt / 2:00 pm edt.

CONNEXA SHAREHOLDERS APPROVE TRANSACTION TO ACQUIRE YUANYU ENTERPRISE MANAGEMENT

News

windsor mills, md, may 17, 2024 (globe newswire) -- connexa sports technologies inc. (nasdaq: yyai), the owner of slinger bag and gameface ai, announced that at its agm, held on may 15, the company's shareholders approved the acquisition of yuanyu enterprise management co., limited (“yyem”). pending nasdaq approval of the related change of control, hongyu zhou, the sole shareholder of yyem, will own a controlling interest in connexa.

NEW TUPPERWARE® WOWPOP POPCORN MAKER AND ULTIMATE SILICONE BAGS WIN INTERNATIONAL RED DOT AWARDS FOR OUTSTANDING PRODUCT DESIGN

News

orlando, fla. , april 23, 2024 /prnewswire/ -- tupperware has earned two new recognitions for innovation in product design - receiving the internationally prestigious red dot awards for outstanding product design - for the new tupperware® wowpop microwave popcorn maker and the new collection of tupperware® ultimate silicone slim bags.